ONCOTHERAPY SCIENCE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 74181
 
  
 
C07K PEPTIDES 5779
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 24182
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 23144
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 20105
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0000,915 IMP-3 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAMEAug 31, 17Jan 04, 18[A61K, C07K]
2017/0362,287 GPC3 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAMEDec 04, 15Dec 21, 17[A61K, C12Q, C12N, G01N, C07K]
2014/0308,678 SMYD2 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSISJun 29, 12Oct 16, 14[G01N]
2014/0094,387 SUV39H2 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSISMay 31, 12Apr 03, 14[C12Q]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896492 HJURP peptides and vaccines including the sameJun 29, 16Feb 20, 18[A61K, C07K]
9849166 TOPK peptides and vaccines including the sameJul 06, 16Dec 26, 17[A61K, C12N, G01N, C07K]
9770498 IMP-3 epitope peptides for TH1 cells and vaccines containing the sameMay 22, 14Sep 26, 17[A61K, C07K]
9745343 Method of inducing an immune response by administering WDRPUH epitope peptidesJul 21, 15Aug 29, 17[A61K, C12N, C07K]
9725490 ERAP1-derived peptide and use thereofJul 27, 12Aug 08, 17[A61K, C12N, G01N, C07K]
9687538 CDCA1 epitope peptides for Th1 cells and vaccines containing the sameJul 09, 13Jun 27, 17[A61K, C12N, C07K]
9644010 LY6K epitope peptides for TH1 cells and vaccines containing the sameJul 09, 13May 09, 17[A61K, C12N, C07K]
9597382 KNTC2 peptides and vaccines containing the sameMar 11, 14Mar 21, 17[A61K, G01N, C07K]
9585948 TOMM34 peptides and vaccines including the sameJul 27, 15Mar 07, 17[A61K, C12N, G01N, C07K]
9561265 KIF20A epitope peptides for TH1 cells and vaccines containing the sameJul 09, 13Feb 07, 17[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0359,864 PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDESAbandonedMar 08, 13Dec 17, 15[A61K]
2014/0199,335 C1ORF59 PEPTIDES AND VACCINES INCLUDING THE SAMEAbandonedMar 06, 14Jul 17, 14[C07K]
2014/0186,381 EPITOPE PEPTIDES DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 AND VACCINES CONTAINING THESE PEPTIDESAbandonedJan 21, 14Jul 03, 14[A61K]
2014/0134,637 METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCERAbandonedApr 22, 11May 15, 14[G01N]
8663647 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptidesExpiredAug 03, 12Mar 04, 14[A61K]
8642724 Colon cancer related gene TOM34WithdrawnJul 21, 06Feb 04, 14[A61K]
8574585 KDR peptides and vaccines comprising the sameExpiredJun 12, 12Nov 05, 13[A61K, C07K]
8574586 KDR peptides and vaccines comprising the sameExpiredJun 12, 12Nov 05, 13[A61K, C07K]
2013/0287,805 C18ORF54 PEPTIDES AND VACCINES INCLUDING THE SAMEAbandonedOct 19, 11Oct 31, 13[A61K]
8563516 Foxp3 peptide vaccineExpiredDec 26, 07Oct 22, 13[A61P]
8530430 TTK peptides and vaccines including the sameExpiredMay 10, 10Sep 10, 13[A61K]
2013/0224,234 TTLL4 PEPTIDES AND VACCINES CONTAINING THE SAMEAbandonedSep 06, 11Aug 29, 13[C12N, C07K]
2013/0203,625 SUV420H1 AND SUV420H2 AS TARGET GENES FOR CANCER THERAPY AND DIAGNOSISAbandonedAug 18, 11Aug 08, 13[C12Q, G01N]
2013/0137,748 WHSC1 AND WHSC1L1 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSISAbandonedFeb 02, 11May 30, 13[C12Q, C12N, G01N]
2013/0108,664 CDCA5 PEPTIDES AND VACCINES INCLUDING THE SAMEAbandonedApr 07, 11May 02, 13[C07K]
8420329 Methods for diagnosing or treating prostate cancerExpiredNov 18, 09Apr 16, 13[G01N]
2013/0084,578 BREAST CANCER RELATED GENE ZNFN3A1AbandonedMar 30, 11Apr 04, 13[C12Q]
8367799 TEM8 peptides and vaccines comprising the sameExpiredApr 10, 08Feb 05, 13[C07K]
2012/0328,638 MYBL2 PEPTIDES AND VACCINES CONTAINING THE SAMEAbandonedDec 02, 10Dec 27, 12[A61K, C12N, A61P, C07K]
2012/0308,590 IMP-3 OLIGOPEPTIDES AND VACCINES INCLUDING THE SAMEAbandonedNov 30, 10Dec 06, 12[A61K, C07H, C12N, A61P, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.